SPARCL1 and cancer: In recent years, SPARCL1 has been extensively studied in cancer and could be a potential target for cancer therapy [15], and it has recently been reported that SPARCL1 regulates adipogenesis in mice [16], but the exact mechanism is unknown and there are limited studies in sheep lipid metabolic processes.